References
- Howard MR, Turnbull AJ, Morley P, Hollier P, Webb R, Clarke A. A prospective study of the prevalence of undiagnosed coeliac disease in laboratory defined iron and folate deficiency. J Clin Pathol 2002; 55: 754–7
- Bode S, Gudmand-Hoyer E. Symptoms and haematologic features in consecutive adult coeliac patients. Scand J Gastroenterol 1996; 31: 54–60
- Dickey W. Low serum B12 is common in coeliac disease and is not due to autoimmune gastritis. Eur J Gastroenterol Hepatol 2002; 14: 425–7
- Dahele A, Ghosh S. Vitamin B12 deficiency in untreated celiac disease. Am J Gastroenterol 2001; 96: 745–50
- Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J. 2002; 325: 1202–8
- The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002;288:2015–22.
- Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369: 1876–82
- Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000; 74: 1196–9
- McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004; 350: 2042–9
- Van Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SMF, van der Klift M, de Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fractures. N Engl J Med 2004; 350: 2033–41
- Tata LJ, Card TR, Logan RF, Hubbard RB, Smith CJ, West J. Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology. 2005; 128: 849–55
- Ludvigsson JF, Michaelsson K, Ekbom A, Montgomery SM. Coeliac disease and the risk of fractures: a general population-based cohort study. Aliment Pharmacol Ther 2007; 25: 273–85
- Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005;84:806–12.
- Eussen SJPM, de Groot LCPGM, Clarke R, Schneede J, Ueland PM, Willebrord D, et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency. A dose finding trial. Arch Intern Med 2005; 165: 1167–72
- McKinley MC, McNulty H, McPartlin J, Strain JJ, Pentieva K, Ward M, et al. Low-dose vitamin B6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 2001; 73: 759–64
- McNulty H, Dowey L, Strain JJ, Dunne A, Ward M, Molloy AM, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C- > T polymorphism. Circulation 2006; 113: 74–80
- United European Gastroenterology Week Working Group. When is a coeliac a coeliac? Eur J Gastroenterol Hepatol 2001;13:1123–8.
- Leino A. Fully automated measurement of total homocysteine in plasma and serum using the Abbot IMx analyser. Clin Chem 1999; 45: 569–71
- Molloy AM, Scott JM. Microbiological assay for serum, plasma and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 1997; 281: 43–53
- Kelleher BP, O'Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991; 44: 592–5
- Bates CJ, Pentieva KD, Mathes N, MacDonald A. A simple, sensitive and reproducible assay for pyridoxal phosphate in human plasma. Clin Chim Acta 1999; 280: 101–11
- Powers HJ, Bates CJ, Duerden JM. Effects of riboflavin deficiency in rats on some aspects of iron metabolism. Int J Vitam Nutr Res 1983; 53: 371–6
- Dickey W, Kearney N. Overweight in celiac disease: prevalence, clinical characteristics and effect of a gluten-free diet. Am J Gastroenterol 2006; 101: 2356–9
- Gefel D, Doncheva M, Ben-Valid E, el Wahab-Daraushe A, Lugassy G, Sela BA. Recurrent stroke in a young patient with celiac disease and hyperhomocysteinemia. Isr Med Assoc J 2002; 4: 222–3
- Gabrielli M, Santoliquido A, Gasbarrini G, Pola P, Gasbarrini A. Latent coeliac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link?. Thromb Haemost 2003; 89: 203–4
- Grigg AP. Deep venous thrombosis as the presenting feature in a patient with coeliac disease and homocysteinaemia. Aust NZ J Med 1999; 29: 566–7
- Saibeni S, Lecchi A, Meucci G, Cattaneo M, Taglrabue L, Rondonotti E, et al. Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gastroenterol Hepatol 2005; 3: 574–80
- Hallert C, Grant C, Grehn S, Granno C, Hulten S, Midhagens G, et al. Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther 2002; 16: 1333–9
- Thompson T. Thiamin, riboflavin and niacin contents of the gluten-free diet: is there cause for concern?. J Am Dietet Assoc 1999; 99: 858–62
- Madigan SM, Tracey F, McNulty H, Eaton-Evans J, Coulter J, McCartney H, et al. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people. Am J Clin Nutr 1998; 68: 389–95
- The National Diet and Nutrition Survey (NDNS): Adults aged 19 to 64 years. London: The Stationery Office; 2004.
- Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Drevon CA, Gjessing HK, et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. Arch Intern Med 2006; 166: 88–94
- Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2005; 293: 1082–8
- Molloy AM, Scott JM. Nutrition and metabolism. Curr Opin Lipidology 2005; 16: 494–5
- West J, Logan RF, Card TR, Smith C, Hubbard R. Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol Ther 2004; 20: 73–9
- The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. JAMA 2004;291:565–75.
- The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567–77.
- The Norwegian Vitamin Trial (NORVIT). Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1629–32.
- B-Vitamin Treatment Trialists’ Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. Am Heart J 2006;151:282–7.